Glaucoma related Proteomic Alterations in Human Retina Samples

Area of Science:

• Ophthalmology
• Proteomics
• Molecular Biology

Background:

• Proteomic changes in glaucoma are known from animal models, but human retina studies are scarce.
• Understanding human retinal proteomic alterations is crucial for glaucoma research.

Purpose of the Study:

• To investigate glaucoma-associated proteomic changes in human retina samples.
• To identify novel protein biomarkers for glaucoma using advanced mass spectrometry.

Main Methods:

• Utilized a mass spectrometry (MS) workflow to analyze proteomic profiles of human retina samples from glaucoma and control donors.
• Identified over 600 proteins with high confidence (FDR < 1%).
• Validated candidate proteins using Accurate Inclusion Mass Screening (AIMS), immunostaining, and laser capture microdissection (LCM).

Main Results:

• Observed distinct proteomic changes in approximately 10% of identified proteins, particularly those in mitochondrial and nuclear pathways.
• Found significant alterations (p < 0.05) or tendencies (p < 0.1) in numerous proteins involved in cellular development, stress, and cell death.
• Identified an increase in stress-related proteins and a decrease in novel glaucoma candidates: ADP/ATP translocase 3 (ANT3), PC4 and SRFS1-interacting protein 1 (DFS70), and methyl-CpG-binding protein 2 (MeCp2).

Conclusions:

• The study provides a detailed view of the human retina proteome in glaucoma.
• Highlights ANT3, DFS70, and MeCp2 as potential new molecular players associated with glaucoma.
• The findings pave the way for developing new diagnostic and therapeutic strategies for glaucoma.